What is Semaglutide?

Semaglutide is the active pharmaceutical ingredient that has transformed weight loss treatment worldwide. As a GLP-1 receptor agonist, it works by mimicking a natural hormone in your body that regulates appetite and blood sugar. Available under brand names Wegovy (for weight management) and Ozempic (for diabetes), semaglutide has helped millions of people achieve significant, sustained weight loss when combined with lifestyle modifications.

Understanding Semaglutide

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This hormone plays several important roles in metabolism, including signaling fullness to your brain and helping regulate blood sugar levels.

Developed by Novo Nordisk, semaglutide is a synthetic version of GLP-1 that has been modified to last much longer in your body than natural GLP-1. While natural GLP-1 breaks down within minutes, a single dose of semaglutide remains active for about a week, which is why it only requires weekly injections.

How Semaglutide Promotes Weight Loss

Semaglutide achieves weight loss through multiple mechanisms that work together to reduce caloric intake and improve metabolic function.

Appetite Suppression

The most significant effect of semaglutide is its impact on appetite. GLP-1 receptors are located in several brain regions that control hunger and food intake, including the hypothalamus. When semaglutide activates these receptors, it sends strong satiety signals that reduce hunger and food cravings.

People taking semaglutide consistently report feeling satisfied with smaller portions. Many describe a reduction in "food noise" - the constant thoughts about food that can make weight loss so challenging. This psychological effect can be as important as the physical appetite reduction.

Delayed Gastric Emptying

Semaglutide slows the rate at which food leaves your stomach and enters your small intestine. This delayed gastric emptying means you feel full longer after eating. While this effect contributes to weight loss, it is also responsible for some gastrointestinal side effects, particularly early in treatment. Learn more in our GLP-1 side effects guide.

Improved Blood Sugar Control

While primarily relevant for people with diabetes, semaglutide's blood sugar-lowering effects benefit weight loss in everyone. By improving insulin sensitivity and reducing blood sugar spikes after meals, semaglutide helps your body use calories more efficiently and reduces the tendency to store excess energy as fat.

Clinical Evidence

Semaglutide's effectiveness for weight loss is supported by extensive published clinical research involving thousands of participants.

The Primary Weight Loss Study

The landmark study included nearly 2,000 adults with obesity who received either semaglutide 2.4mg weekly or placebo for 68 weeks. The results were impressive:

• Clinically significant average weight loss with semaglutide, far exceeding placebo
• The vast majority of semaglutide users lost at least 5% of body weight
• A significant proportion achieved 10% or greater weight loss
• Many participants achieved major weight reduction
• One-third achieved 20% or greater weight loss

For detailed expectations, see our GLP-1 weight loss timeline.

Beyond Weight Loss

Published clinical research also demonstrated significant improvements in cardiometabolic health:

• Reduced blood pressure
• Improved cholesterol profiles
• Decreased waist circumference
• Reduced inflammatory markers
• Improved quality of life scores

Wegovy Dosing Protocol

Wegovy (semaglutide 2.4mg) follows a gradual dose escalation protocol to minimize side effects. This slow titration allows your body to adjust to the medication. For complete dosing information, see our semaglutide dosing guide.

The injection is administered subcutaneously (under the skin) in the abdomen, thigh, or upper arm. For step-by-step instructions, see our semaglutide injection guide.

Side Effects and Management

Most side effects of semaglutide are gastrointestinal and typically improve as your body adjusts to the medication. The slow dose titration is designed to minimize these effects.

Common Side Effects

• Nausea: Most common, affecting 40-45% initially but typically improves
• Diarrhea: Affects about 30% of users
• Vomiting: More common during dose escalation
• Constipation: Due to slower gastric motility
• Abdominal pain: Usually mild and temporary
• Headache: More common in early treatment

For strategies to minimize these effects, read our comprehensive guide on managing GLP-1 nausea.

Serious but Rare Side Effects

While uncommon, some serious side effects require medical attention:

• Pancreatitis (inflammation of the pancreas)
• Gallbladder problems
• Kidney problems
• Serious allergic reactions
• Changes in vision (in people with diabetes)

Who is a Good Candidate?

Semaglutide for weight loss is appropriate for adults who meet certain criteria:

• BMI of 30 or higher (obesity), or
• BMI of 27 or higher with at least one weight-related condition
• Have not achieved adequate weight loss through diet and exercise alone
• Are willing to make long-term lifestyle changes
• Have no contraindications to the medication

For detailed information on who should avoid GLP-1 medications, see our article on contraindications to GLP-1 therapy.

Semaglutide vs Tirzepatide

Tirzepatide (Mounjaro/Zepbound) is a newer medication that works on both GLP-1 and GIP receptors. In published comparisons, tirzepatide has shown greater weight loss than semaglutide, as it targets both GLP-1 and GIP pathways.

However, semaglutide has advantages including:

• Longer track record of safety data
• More extensive cardiovascular outcome studies
• Availability in oral form (Rybelsus) for diabetes
• Generally lower cost

For a complete comparison, see our tirzepatide vs semaglutide article.

Getting Semaglutide in Nigeria

While brand-name Wegovy is not currently registered with NAFDAC, compounded semaglutide is available through licensed providers in Nigeria. These providers source pharmaceutical-grade semaglutide and prepare it under proper conditions with medical oversight.

Key considerations when sourcing semaglutide:

• Verify the provider's credentials and medical supervision
• Ensure proper cold-chain storage is maintained
• Confirm pharmaceutical-grade ingredients are used
• Expect ongoing medical monitoring

For more on access and costs, see our GLP-1 cost guide and how to get GLP-1 medications.

Maximizing Results with Semaglutide

Semaglutide works best as part of a comprehensive weight loss plan:

• Protein intake: Aim for 1.2-1.5g protein per kg body weight to preserve muscle mass
• Regular exercise: Include both cardio and strength training
• Hydration: Drink plenty of water to help manage side effects
• Mindful eating: Listen to your reduced appetite signals
• Consistent timing: Take your injection on the same day each week
• Medical monitoring: Regular follow-up with healthcare providers

Long-term Considerations

Research suggests that weight tends to return after stopping semaglutide, with participants regaining about two-thirds of lost weight within a year of discontinuation. This highlights the importance of viewing semaglutide as a long-term treatment rather than a short-term fix.

For information on what happens when treatment ends, see our article on stopping GLP-1 medications.

Conclusion

Semaglutide represents a major advance in weight loss treatment, offering a way to address the biological factors that make weight loss so challenging. With clinically significant weight loss, improvements in cardiometabolic health, and a well-established safety profile, it has become a valuable tool for people struggling with obesity.

Success with semaglutide requires commitment to lifestyle changes, patience during the dose titration period, and ongoing medical supervision. For those who qualify, it can be a powerful addition to a comprehensive weight management strategy.